Plasma Ip(a) Concentration is Inversely Correlated with the Ratio of Kringle IV/Kringle V Encoding Domains in the Apo(a) Gene
Overview
Authors
Affiliations
Plasma Lp(a) levels correlate with atherosclerosis susceptibility. This lipoprotein consists of an LDL-like particle attached to a large glycoprotein called apo(a). Apo(a) is a complex glycoprotein containing multiple Kringle domains, found to be highly homologous to plasminogen Kringle IV, and a single Kringle domain homologous to plasminogen Kringle V. Lp(a) levels appear to be inversely correlated with apo(a) size in a given individual. In this study, we have used probes specific to the Kringles IV and V domains of apo(a) cDNA in quantitative Southern blotting analysis. By this method, we have determined the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene of 53 unrelated individuals with different plasma concentrations of Lp(a). This ratio was found to be inversely correlated with log Lp(a) levels (r = -0.90, P less than 0.0001) and directly correlated with apo(a) apparent molecular weight (Mr) (r = 0.79, P less than 0.0001). In summary, by showing that Lp(a) concentrations and apo(a) apparent size are highly correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene, we provide a DNA marker for this atherosclerosis risk factor as well as an important insight into the genetic mechanism regulating Lp(a) levels.
Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study.
Arora P, Kalra R, Callas P, Alexander K, Zakai N, Wadley V Arterioscler Thromb Vasc Biol. 2019; 39(4):810-818.
PMID: 30786745 PMC: 6511401. DOI: 10.1161/ATVBAHA.118.311857.
Tuteja S, Wang L, Dunbar R, Chen J, DerOhannessian S, Marcovina S Pharmacogenet Genomics. 2017; 27(8):285-293.
PMID: 28628560 PMC: 5548439. DOI: 10.1097/FPC.0000000000000289.
Song Z, Cao H, Wu H, Zhou L, Qin L Iran Red Crescent Med J. 2016; 18(6):e35387.
PMID: 27621937 PMC: 5010879. DOI: 10.5812/ircmj.35387.
Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis.
Wang H, Hong C, Lewis J, Zhu Y, Wang X, Chu X G3 (Bethesda). 2016; 6(11):3525-3532.
PMID: 27605514 PMC: 5100851. DOI: 10.1534/g3.116.034702.
Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans.
Graham M, Viney N, Crooke R, Tsimikas S J Lipid Res. 2015; 57(3):340-51.
PMID: 26538546 PMC: 4767000. DOI: 10.1194/jlr.R052258.